Development of a novel, fibrin-specific PET tracer

T.R. van Mourik, M. Claesener, K. Nicolay, H. Grüll

Onderzoeksoutput: Bijdrage aan tijdschriftTijdschriftartikelAcademicpeer review

1 Citaat (Scopus)


Fibrin deposition is observed in several diseases such as atherosclerosis, deep vein thrombosis, and also tumors, where it contributes to the formation of mature tumor stroma. The aim of this study was to develop a gallium-labeled peptide tracer on the basis of the fibrin-targeting peptide Epep for PET imaging of fibrin deposition. For this purpose, the peptide Epep was modified with a NOTA moiety for radiolabeling with 67Ga and 68Ga and compared with the earlier validated 111In-DOTA-Epep tracer. In vitro binding assays of 67Ga-NOTA-Epep displayed an enhanced retention as compared to previously published data showing binding of 111In-DOTA-Epep to human (84.0 ± 0.6 vs 66.6 ± 1.4 %Dose) and mouse derived fibrin clots (83.5 ± 1.7 vs 74.2 ± 2.4% Dose). In vivo blood kinetics displayed a bi-phasic elimination profile (t1/2,α = 2.6 ± 1.0 minutes and t1/2,β = 15.8 ± 1.3 minutes) and ex vivo biodistribution showed low blood values at 4 hours post injection and a low uptake in nontarget tissue (<0.2 %ID/g; kidneys, 1.9%ID/g). In conclusion, taking into account the ease of radiolabeling and the promising in vitro and in vivo studies, gallium-labeled Epep displays the potential for further development towards a PET tracer for fibrin deposition.

Originele taal-2Engels
Pagina's (van-tot)286-293
Aantal pagina's8
TijdschriftJournal of Labelled Compounds and Radiopharmaceuticals
Nummer van het tijdschrift6
StatusGepubliceerd - 30 mei 2017

Vingerafdruk Duik in de onderzoeksthema's van 'Development of a novel, fibrin-specific PET tracer'. Samen vormen ze een unieke vingerafdruk.

  • Citeer dit